CORRESP Filing
Cabaletta Bio, Inc.
Date: Aug. 13, 2025 · CIK: 0001759138 · Accession: 0001193125-25-179840
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289339
Letter
Re: Cabaletta Bio, Inc.: Registration Statement on Form S-3 filed August 7, 2025 (File No. 333-289339) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Cabaletta Bio, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to August 15, 2025, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact Finnbarr Murphy, Esq. of Goodwin Procter LLP at (212) 459-7257.
Cabaletta Bio, Inc. 2929 Arch Street, Suite 600 Philadelphia, Pennsylvania 19104 August 13, 2025 Via EDGAR Transmission Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky
Sincerely,
CABALETTA BIO, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Cabaletta Bio, Inc. 2929 Arch Street, Suite 600 Philadelphia, Pennsylvania 19104 August 13, 2025 Via EDGAR Transmission Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Cabaletta Bio, Inc.: Registration Statement on Form S-3 filed August 7, 2025 (File No. 333-289339) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), Cabaletta Bio, Inc. (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to August 15, 2025, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act. If you have any questions regarding this request, please contact Finnbarr Murphy, Esq. of Goodwin Procter LLP at (212) 459-7257. Sincerely, CABALETTA BIO, INC. /s/ Steven Nichtberger, M.D. Steven Nichtberger, M.D. President and Chief Executive Officer cc: Michael Gerard, Esq., Cabaletta Bio, Inc. Mitchell S. Bloom, Esq., Goodwin Procter LLP Finnbarr Murphy, Esq., Goodwin Procter LLP